Trial intelligence / Profile preview

Bupivacaine wound infiltration for post-caesarean analgesia

PACTR202404745779132Phase 0Recruiting

Sponsor
abdullahi musa olatunji
Start
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 0 trial of bupivacaine, sponsored by abdullahi musa olatunji. Started Oct 2023; status: recruiting.

02

Drugs

bupivacaine

Beyond the preview

Go deeper on PACTR202404745779132.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202404745779132.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call